Tehran (IP) - Head of Pasteur Institute of Iran Alireza Biglari said although there is not enough information about the identity of coronavirus in the world, effective steps have been taken in plasma therapy in Iran.

Iran PressIran News: Answering the questions raised by Iran Press about the effect of plasma therapy on the treatment of COVID-19 patients, Biglari pointed that "This program has begun with joint efforts of Health ministry and Blood Transfusion Organization and we need to wait to release the results.

Biglari went on to say that the number of laboratories which run coronavirus test has increased from 3 to 120, and 15,000 tests can be done on a daily basis.

Referring to two types of Coronavirus diagnosis tests he said that molecular test is valid and reliable although serologic test can show the effect of the virus in the body.

"The number of inpatients has lessened, and people need to rely on our health network system," he concluded.

Pasteur Institute of Iran (IPI) was founded in the heart of Iran's capital, Tehran in the 1920s to pave the way for advanced research and to provide innovative programs in basic and applied medical sciences, and production of biopharmaceuticals and diagnostic kits with special emphasis on infectious diseases.


Read More:

Iran ranks third worldwide in coronavirus clinical trials: WHO

Iran reports lowest coronavirus new deaths with 45

Iran's BTO Chief: Blood reserves remained stable